+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Rapid Microbiology Testing Market Size, Share & Trends Analysis Report By Method, By Application , By Product (Instruments , Reagents & Kits, and Consumables), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 170 Pages
  • April 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5955258
The Latin America, Middle East and Africa Rapid Microbiology Testing Market would witness market growth of 13.1% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Rapid Microbiology Testing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $221 million by 2031. The Argentina market is showcasing a CAGR of 13.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 12.7% during (2024 - 2031).



Microfluidic devices and lab-on-a-chip technologies are revolutionizing this testing by miniaturizing testing platforms, reducing sample volumes, and accelerating assay kinetics. Microfluidic systems enable precise control and manipulation of fluids at the microscale, facilitating rapid nucleic acid amplification, immunoassays, and cell-based assays within compact and portable devices. Lab-on-a-chip platforms integrate sample preparation, amplification, and detection steps into a single disposable cartridge, enabling automated and multiplexed testing with minimal hands-on time.

Furthermore, one of the most significant applications of microfluidic devices in this testing is in nucleic acid amplification assays, such as polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP). Pathogens like bacteria, viruses, and parasites can be found in minutes owing to the quick, highly sensitive, and highly specific amplification of target nucleic acid sequences made possible by microfluidic PCR platforms. By integrating sample preparation, amplification, and detection steps into a single microfluidic cartridge, these systems streamline the testing workflow and minimize the risk of contamination, offering a portable and user-friendly solution for point-of-care diagnostics.

South Africa's food and beverage sector encompasses diverse products, including fresh produce, processed foods, dairy products, beverages, and meat products. As a result of urbanization and population growth, consumer demand for nutritious, high-quality, and secure food products is increasing. As per the data from the Government of South Africa, measured in real terms (constant 2019 prices), total income generated by the food and beverages industry increased by 14.9% in February 2023 compared with February 2022. Positive annual growth rates were recorded for bar sales (35,5%) and food sales (13,8%). In addition, In the UAE's dynamic and multicultural foodservice landscape, ensuring food safety and quality assurance is paramount to maintaining consumer trust, safeguarding public health, and sustaining economic growth. According to the United States Department of Agriculture data, the UAE has the second-largest food service sector within the Arab Gulf Cooperation Council (GCC) region after Saudi Arabia. In 2021, the value of the UAE hotel, restaurant, and institutional sector totaled $12.3 billion, almost a 17 percent increase from 2020. Thus, the rising food & beverage and food service sectors in LAMEA will assist in the growth of the regional market.

Based on Method, the market is segmented into Growth-based Rapid Microbiology Testing, Cellular Component-based Rapid Microbiology Testing, Nucleic Acid-based Rapid Microbiology Testing, Viability-based Rapid Microbiology Testing and Others. Based on Application, the market is segmented into Industrial Testing (Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics & Personal Care Products Testing and Others), Clinical Disease Diagnosis and Research Applications. Based on Product, the market is segmented into Instruments (Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems, Mass Spectrometers, PCR Systems, Bioluminescence & Fluorescence-based Detection Systems, Cytometers, Active Air Samplers and Others), Reagents & Kits, and Consumables. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Market Report Segmentation

By Method
  • Growth-based Rapid Microbiology Testing
  • Cellular Component-based Rapid Microbiology Testing
  • Nucleic Acid-based Rapid Microbiology Testing
  • Viability-based Rapid Microbiology Testing
  • Others
By Application
  • Industrial Testing
  • Food & Beverage Testing
  • Pharmaceutical & Biological Drug Testing
  • Environmental Testing
  • Cosmetics & Personal Care Products Testing
  • Others
  • Clinical Disease Diagnosis
  • Research Applications
By Product
  • Instruments
  • Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems
  • Mass Spectrometers
  • PCR Systems
  • Bioluminescence & Fluorescence-based Detection Systems
  • Cytometers
  • Active Air Samplers
  • Others
  • Reagents & Kits
  • Consumables
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Rapid Microbiology Testing Market, by Method
1.4.2 LAMEA Rapid Microbiology Testing Market, by Application
1.4.3 LAMEA Rapid Microbiology Testing Market, by Product
1.4.4 LAMEA Rapid Microbiology Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Aug - 2023, May) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. LAMEA Rapid Microbiology Testing Market by Method
5.1 LAMEA Growth-based Rapid Microbiology Testing Market by Country
5.2 LAMEA Cellular Component-based Rapid Microbiology Testing Market by Country
5.3 LAMEA Nucleic Acid-based Rapid Microbiology Testing Market by Country
5.4 LAMEA Viability-based Rapid Microbiology Testing Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Rapid Microbiology Testing Market by Application
6.1 LAMEA Industrial Testing Market by Country
6.2 LAMEA Rapid Microbiology Testing Market by Industrial Testing Type
6.2.1 LAMEA Food & Beverage Testing Market by Country
6.2.2 LAMEA Pharmaceutical & Biological Drug Testing Market by Country
6.2.3 LAMEA Environmental Testing Market by Country
6.2.4 LAMEA Cosmetics & Personal Care Products Testing Market by Country
6.2.5 LAMEA Others Market by Country
6.3 LAMEA Clinical Disease Diagnosis Market by Country
6.4 LAMEA Research Applications Market by Country
Chapter 7. LAMEA Rapid Microbiology Testing Market by Product
7.1 LAMEA Instruments Market by Country
7.2 LAMEA Rapid Microbiology Testing Market by Instruments Type
7.2.1 LAMEA Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
7.2.2 LAMEA Mass Spectrometers Market by Country
7.2.3 LAMEA PCR Systems Market by Country
7.2.4 LAMEA Bioluminescence & Fluorescence-based Detection Systems Market by Country
7.2.5 LAMEA Cytometers Market by Country
7.2.6 LAMEA Active Air Samplers Market by Country
7.2.7 LAMEA Others Market by Country
7.3 LAMEA Reagents & Kits Market by Country
7.4 LAMEA Consumables Market by Country
Chapter 8. LAMEA Rapid Microbiology Testing Market by Country
8.1 Brazil Rapid Microbiology Testing Market
8.1.1 Brazil Rapid Microbiology Testing Market by Method
8.1.2 Brazil Rapid Microbiology Testing Market by Application
8.1.2.1 Brazil Rapid Microbiology Testing Market by Industrial Testing Type
8.1.3 Brazil Rapid Microbiology Testing Market by Product
8.1.3.1 Brazil Rapid Microbiology Testing Market by Instruments Type
8.2 Argentina Rapid Microbiology Testing Market
8.2.1 Argentina Rapid Microbiology Testing Market by Method
8.2.2 Argentina Rapid Microbiology Testing Market by Application
8.2.2.1 Argentina Rapid Microbiology Testing Market by Industrial Testing Type
8.2.3 Argentina Rapid Microbiology Testing Market by Product
8.2.3.1 Argentina Rapid Microbiology Testing Market by Instruments Type
8.3 UAE Rapid Microbiology Testing Market
8.3.1 UAE Rapid Microbiology Testing Market by Method
8.3.2 UAE Rapid Microbiology Testing Market by Application
8.3.2.1 UAE Rapid Microbiology Testing Market by Industrial Testing Type
8.3.3 UAE Rapid Microbiology Testing Market by Product
8.3.3.1 UAE Rapid Microbiology Testing Market by Instruments Type
8.4 Saudi Arabia Rapid Microbiology Testing Market
8.4.1 Saudi Arabia Rapid Microbiology Testing Market by Method
8.4.2 Saudi Arabia Rapid Microbiology Testing Market by Application
8.4.2.1 Saudi Arabia Rapid Microbiology Testing Market by Industrial Testing Type
8.4.3 Saudi Arabia Rapid Microbiology Testing Market by Product
8.4.3.1 Saudi Arabia Rapid Microbiology Testing Market by Instruments Type
8.5 South Africa Rapid Microbiology Testing Market
8.5.1 South Africa Rapid Microbiology Testing Market by Method
8.5.2 South Africa Rapid Microbiology Testing Market by Application
8.5.2.1 South Africa Rapid Microbiology Testing Market by Industrial Testing Type
8.5.3 South Africa Rapid Microbiology Testing Market by Product
8.5.3.1 South Africa Rapid Microbiology Testing Market by Instruments Type
8.6 Nigeria Rapid Microbiology Testing Market
8.6.1 Nigeria Rapid Microbiology Testing Market by Method
8.6.2 Nigeria Rapid Microbiology Testing Market by Application
8.6.2.1 Nigeria Rapid Microbiology Testing Market by Industrial Testing Type
8.6.3 Nigeria Rapid Microbiology Testing Market by Product
8.6.3.1 Nigeria Rapid Microbiology Testing Market by Instruments Type
8.7 Rest of LAMEA Rapid Microbiology Testing Market
8.7.1 Rest of LAMEA Rapid Microbiology Testing Market by Method
8.7.2 Rest of LAMEA Rapid Microbiology Testing Market by Application
8.7.2.1 Rest of LAMEA Rapid Microbiology Testing Market by Industrial Testing Type
8.7.3 Rest of LAMEA Rapid Microbiology Testing Market by Product
8.7.3.1 Rest of LAMEA Rapid Microbiology Testing Market by Instruments Type
Chapter 9. Company Profiles
9.1 BioMerieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 QuidelOrtho Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Trials and Approvals:
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Neogen Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product launches and Product expansions:
9.6.6 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Bruker Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.6 SWOT Analysis
9.9 Charles River Laboratories International, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 SWOT Analysis
9.10. Becton, Dickinson, and Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.6 SWOT Analysis

Companies Mentioned

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Methodology

Loading
LOADING...